By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Precision Biosciences said today that a federal court has stayed patent litigation brought against it by Cellectis.

Following a "non-final" decision by the US Patent and Trademark Office in the spring, the US District Court for the Eastern District of North Carolina has ordered all proceedings in the case be suspended until the USPTO has finished its reexamination of US Patents 6,610,545 and 7,309,605, to which Cellectis holds exclusive rights.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.